GoHealth, Inc. (NASDAQ:GOCO) has a beta value of 0 and has seen 465,788 shares traded in the last trading session. The company, currently valued at $3.74 Billion, closed the last trade at $11.63 per share which meant it lost -$0.39 on the day or -3.24% during that session. The GOCO stock price is -125.71% off its 52-week high price of $26.25 and 13.84% above the 52-week low of $10.02. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.53 Million shares traded. The 3-month trading volume is 1.21 Million shares.
The consensus among analysts is that GoHealth, Inc. (GOCO) is a Buy stock at the moment, with a recommendation rating of 1.9. None of the analysts rate the stock as a Sell, while 1 rate it as Overweight. 1 out of 11 have rated it as a Hold, with 9 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is $0.45.
GoHealth, Inc. (NASDAQ:GOCO) trade information
Wall Street analysts have a consensus price target for the stock at $20.1, which means that the shares’ value could jump 72.83% from current levels. The projected low price target is $14 while the price target rests at a high of $26. In that case, then, we find that the current price level is +123.56% off the targeted high while a plunge would see the stock lose 20.38% from current levels.
GoHealth, Inc. (GOCO) estimates and forecasts
Earnings growth for 2020 is a modest -246.1%.
GoHealth, Inc. (NASDAQ:GOCO)’s Major holders
Insiders own 0.12% of the company shares, while shares held by institutions stand at 100.92% with a share float percentage of 101.04%. Investors are also buoyed by the number of investors in a company, with GoHealth, Inc. having a total of 116 institutions that hold shares in the company. The top two institutional holders are Centerbridge Partners, L.P. with over 40.68 Million shares worth more than $529.9 Million. As of September 29, 2020, Centerbridge Partners, L.P. held 48.33% of shares outstanding.
The other major institutional holder is Price (T.Rowe) Associates Inc, with the holding of over 5.81 Million shares as of September 29, 2020. The firm’s total holdings are worth over $75.69 Million and represent 6.9% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Price (T.Rowe) Mid Cap Growth Fund and AB Discovery Growth Fund. As of September 29, 2020, the former fund manager holds about 3.27% shares in the company for having 2750000 shares of worth $35.82 Million while later fund manager owns 1.5 Million shares of worth $19.59 Million as of September 29, 2020, which makes it owner of about 1.79% of company’s outstanding stock.